Marshall Wace’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Marshall Wace’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-277,624	Closed	-$2.89M	–	3203
2022 Q4	$2.89M	Hold	277,624	–	–	0.01%	1528
2022 Q3	$2.83M	Hold	277,624	–	–	0.01%	1789
2022 Q2	$2.82M	Hold	277,624	–	–	0.01%	1761
2022 Q1	$2.8M	Hold	277,624	–	–	0.01%	1832
2021 Q4	$2.77M	Buy	+277,624	New	+$2.77M	0.01%	1833

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Marshall Wace's OCEA Position: Q1 2023 in Review

Marshall Wace sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 277,624 shares — an estimated $2.89M sold.

Marshall Wace first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $2.89M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

Marshall Wace reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 277,624 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $2.89M.
Marshall Wace first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Marshall Wace's Ocean Biomedical, Inc. Common Stock position peaked at $2.89M in Q4 2022.
17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.